Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, M.
Right arrow Articles by Tamura, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, M.
Right arrow Articles by Tamura, M.
(Chest. 1992;102:21S-25S.)
© 1992 American College of Chest Physicians

Clinical Features of BOOP in Japan

Masahiko Yamamoto M.D., F.C.C.P.1; Yasutaka Ina M.D.1; Masanori Kitaichi M.D.2; Michiyoshi Harasawa M.D., F.C.C.P.3; and Masashi Tamura M.D., F.C.C.P.4

1 The Second Department of Internal Medicine, Nagoya City University
2 Chest Disease Research Institute, Kyoto University
3 Chief, Research Committees on Interstitial Pulmonary Diseases, Ministry of Health and Welfare of Japan., Tokyo Teishin Hospital
4 Chief, Research Committees on Diffuse Pulmonary Disease, Ministry of Health and Welfare of Japan., The Third Department of Internal Medicine, Iwate Medical University, Tokyo, Japan.

The clinical features derived from 29 BOOP cases diagnosed by open lung biopsy specimen in Japan are summarized as follows: (1) 70% of BOOP cases in Japan were idiopathic, while 20% were associated with collagen vascular disease. (2) BOOP could be classified into 2 major types (type 1 and type 2). Some that could not be classified into those 2 types were unclassified. Type 1 (wandering type) showed bilateral multiple patchy densities that wandered throughout the pulmonary fields. Thirteen cases were classified as type 1. Type 2 (not wandering type) showed bilateral basilar micronodular densities. Eight cases were classified as type 2. (3) Type 1 more frequently showed fever, leukocytosis, accelerated ESR, and positive CRP than type 2, indicating stronger inflammatory processes. (4) Two of the 29 patients with BOOP died. Those 2 patients belonged to the idiopathic group. One patient died of BOOP and the other patient died of fungal infection probably induced by corticosteroid therapy. [See Table 7 and 8 in source pdf].







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American College of Chest Physicians.